FDAnews Drug Daily Bulletin

First Trial of Vaccine to Treat Parkinson’s Disease Begins

The Austrian company AFFiRiS A.G. of Vienna said this week it has begun the first-ever clinical trials of a vaccine to treat Parkinson’s disease. The study of as many as 32 patients is designed to test the safety and tolerability of the vaccine, called PD01A.
Los Angeles Times